ziprasidone hydrochloride

Product NDC
64725-2164
11-digit product format
647252164
Labeler code
64725
Product ID
64725-2164_85fb1966-59ca-453a-8a7f-17092ef729aa
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ziprasidone hydrochloride
Dosage form
CAPSULE
Route
ORAL
Labeler
TYA Pharmaceuticals
Application
ANDA077562
Marketing category
ANDA
Marketing start
2013-02-13
Marketing end
0000-00-00
Substance
ZIPRASIDONE HYDROCHLORIDE
Active strength
20 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
defe29d6-6a09-c3aa-4400-b1130380ccc3Product name520231206

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
64725-2164-1ziprasidone hydrochloride30 in 1 CONTAINERCAPSULE304

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ZIPRASIDONE HYDROCHLORIDEACTIVE INGREDIENT216X081ORUZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4
ZIPRASIDONEACTIVE MOIETY6UKA5VEJ6XZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4
AMMONIAINACTIVE INGREDIENT5138Q19F1XZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4
ANHYDROUS LACTOSEINACTIVE INGREDIENT3SY5LH9PMKZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4
CALCIUM SILICATEINACTIVE INGREDIENTS4255P4G5MZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4
CARBOXYMETHYLCELLULOSEINACTIVE INGREDIENT05JZI7B19XZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QPZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRTZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357ZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4
GELATININACTIVE INGREDIENT2G86QN327LZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30ZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3ZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4
SHELLACINACTIVE INGREDIENT46N107B71OZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
64725-2164ZIPRASIDONE HYDROCHLORIDE CAPSULE [TYA PHARMACEUTICALS]4Legacy NDC, 1 package rows20140921_5752ef72-c515-4ead-a359-69d4761ad7f4.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
314286ziprasidone HCl 20 MG Oral CapsulePSN5752ef72-c515-4ead-a359-69d4761ad7f44
313778ziprasidone HCl 80 MG Oral CapsulePSN5752ef72-c515-4ead-a359-69d4761ad7f44
314286ziprasidone 20 MG Oral CapsuleSCD5752ef72-c515-4ead-a359-69d4761ad7f44
313778ziprasidone 80 MG Oral CapsuleSCD5752ef72-c515-4ead-a359-69d4761ad7f44
314286ziprasidone (as ziprasidone HCl monohydrate) 20 MG Oral CapsuleSY5752ef72-c515-4ead-a359-69d4761ad7f44
313778ziprasidone (as ziprasidone hydrochloride monohydrate) 80 MG Oral CapsuleSY5752ef72-c515-4ead-a359-69d4761ad7f44

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
64725-2164-16472521640130 in 1 CONTAINERHistorical